SpectraCure´s main owner subscribes in full for his share
SpectraCure's main owner and CEO Masoud Khayyami subscribes in full through his company Cardeon Futuring Finance his share in the company's warrants program TO3, corresponding to 1 653 382 warrants. Cardeon Futuring Finance's total holding in SpectraCure after the issue amounts to 2 480 073 shares.Prior to the acquisition Masoud Khayyami, privately and with companies owned 13 227 059 shares, corresponding to 16.21% of capital and votes. Following the acquisition, Masoud Khayyami, privately and with companies owns 14 053 750 shares. Subscription of shares supported by the warrants in